{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:38:15Z","timestamp":1792543095777,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":92,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NSFC82270050"],"award-info":[{"award-number":["NSFC82270050"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Pulmonary arterial hypertension (PAH) is a life-threatening disorder marked by progressive elevation of pulmonary vascular resistance and ultimate right heart failure. Its diagnosis and risk stratification largely depend on invasive right heart catheterization (RHC). This study aimed to integrate routine laboratory and echocardiographic data to develop a novel multi-organ prognostic indicator and construct non-invasive hemodynamic estimation prediction models. This was a multi-center retrospective study enrolling a total of 44 routine laboratory and echocardiographic indices of pre-capillary pulmonary hypertension. Key prognostic variables were screened using Least absolute shrinkage and selection operator-Cox (LASSO-Cox) regression and random survival forest (RSF) analysis. The novel composite index was constructed based on correlation analysis with hemodynamic parameters. Prognostic performance was evaluated using Cox regression, Time-Dependent Receiver Operating Characteristic (time-dependent ROC) curve analysis, stratified analysis, and decision curve analysis (DCA). Linear prediction models for invasive hemodynamic parameters were established using variable selection and internal validation. A total of 179 patients with pre-capillary pulmonary hypertension were included. Using LASSO-Cox and random survival forest, 13 core prognostic variables were identified, including total bilirubin (TB) and B-type natriuretic peptide (BNP). The novel hepatic-cardiac index--TBI (log [total bilirubin \u00d7 BNP]) was constructed and validated as an independent prognostic factor (HR=1.64, 95%CI: 1.287\u20132.09, P=0.0001). Predictive efficacy at 36 months was significantly higher for TBI (area under the curve, AUC = 0.777) than for BNP (AUC = 0.723,\n                    <jats:italic>P<\/jats:italic>\n                    \u202f=\u202f0.021 with false discovery rate [FDR] adjustment). Stratified analysis confirmed that TBI remained prognostic in patients with BNP levels between 200 and 800 pg\/mL (\u03c7\n                    <jats:sup>2<\/jats:sup>\n                    =7.075, P = 0.008). Additionally, non-invasive linear prediction models for mean pulmonary arterial pressure(mPAP), pulmonary vascular resistance (PVR), and PVR\u00d7CO (cardiac output) were established with moderate accuracy (R\n                    <jats:sup>2<\/jats:sup>\n                    =0.575, 0.507, 0.523, respectively) Integration of laboratory and echocardiographic parameters enables improved non-invasive evaluation in pulmonary hypertension. The novel hepatic-cardiac index (TBI, log[TB\u00d7BNP]) serves as a robust and independent prognostic biomarker. Routine non-invasive indices can reliably estimate key hemodynamic parameters in clinical practice.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-62666-1","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T12:38:29Z","timestamp":1784637509000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and validation of novel prognostic hepatic-cardiac index and hemodynamic prediction models in pre-capillary pulmonary hypertension patients"],"prefix":"10.1038","volume":"16","author":[{"given":"Jun","family":"Tong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanxue","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binqian","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menghui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieyan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"issue":"38","key":"62666_CR1","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","volume":"43","author":"M Humbert","year":"2022","unstructured":"Humbert, M. et al. 2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur. Heart J. 43(38), 3618\u20133731 (2022).","journal-title":"Eur. Heart J."},{"issue":"1","key":"62666_CR2","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.chest.2020.08.2069","volume":"159","author":"RL Benza","year":"2021","unstructured":"Benza, R. L. et al. Development and validation of an abridged version of the REVEAL 2.0 risk score calculator, REVEAL lite 2, for use in patients with pulmonary arterial hypertension. Chest 159(1), 337\u2013346 (2021).","journal-title":"Chest"},{"issue":"2","key":"62666_CR3","doi-asserted-by":"publisher","first-page":"012","DOI":"10.1093\/ehjopen\/oead012","volume":"3","author":"A Ahmed","year":"2023","unstructured":"Ahmed, A., Ahmed, S., Kempe, D. & R\u00e5degran, G. A. Evaluation of the European Society of cardiology\/European respiratory society derived three-and four-strata risk stratification models in pulmonary arterial hypertension: introducing an internet-based risk stratification calculator. Eur. Heart J. Open 3(2), 012 (2023).","journal-title":"Eur. Heart J. Open"},{"issue":"6","key":"62666_CR4","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1080\/14397595.2018.1537555","volume":"29","author":"T Uk Kang","year":"2019","unstructured":"Uk Kang, T. et al. Association of hyperuricemia and pulmonary hypertension: a systematic review and meta-analysis. Mod. Rheumatol. 29(6), 1031\u20131041 (2019).","journal-title":"Mod. Rheumatol."},{"key":"62666_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.805415","volume":"9","author":"L Yan","year":"2022","unstructured":"Yan, L. et al. The prognostic impact of serum uric acid on disease severity and 5-year mortality in patients with idiopathic pulmonary artery hypertension. Front. Med. (Lausanne). 9, 805415 (2022).","journal-title":"Front. Med. (Lausanne)."},{"key":"62666_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1395993","volume":"15","author":"A Zinellu","year":"2024","unstructured":"Zinellu, A. & Mangoni, A. A. The association between the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio and systemic sclerosis and its complications: a systematic review and meta-analysis. Front. Immunol. 15, 1395993 (2024).","journal-title":"Front. Immunol."},{"key":"62666_CR7","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0095-2022","author":"A Zinellu","year":"2022","unstructured":"Zinellu, A. et al. Clinical significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in acute exacerbations of COPD: present and future. Eur. Respir. Rev. https:\/\/doi.org\/10.1183\/16000617.0095-2022 (2022).","journal-title":"Eur. Respir. Rev."},{"key":"62666_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20143514","author":"K Jonas","year":"2019","unstructured":"Jonas, K. & Kope\u0107, G. HDL cholesterol as a marker of disease severity and prognosis in patients with pulmonary arterial hypertension. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms20143514 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"62666_CR9","doi-asserted-by":"publisher","first-page":"746","DOI":"10.12659\/MSM.912766","volume":"25","author":"K Jonas","year":"2019","unstructured":"Jonas, K., Mago\u0144, W., Podolec, P. & Kope\u0107, G. Triglyceride-to-high-density lipoprotein cholesterol ratio and systemic inflammation in patients with idiopathic pulmonary arterial hypertension. Med. Sci. Monit. 25, 746\u2013753 (2019).","journal-title":"Med. Sci. Monit."},{"issue":"9","key":"62666_CR10","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.119.009047","volume":"12","author":"K Tello","year":"2019","unstructured":"Tello, K. et al. Validation of the tricuspid annular plane systolic excursion\/systolic pulmonary artery pressure ratio for the assessment of right ventricular-arterial coupling in severe pulmonary hypertension. Circ. Cardiovasc. Imaging. 12(9), e009047 (2019).","journal-title":"Circ. Cardiovasc. Imaging."},{"key":"62666_CR11","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ijcard.2018.01.053","volume":"266","author":"K Tello","year":"2018","unstructured":"Tello, K. et al. Relevance of the TAPSE\/PASP ratio in pulmonary arterial hypertension. Int. J. Cardiol. 266, 229\u2013235 (2018).","journal-title":"Int. J. Cardiol."},{"issue":"3","key":"62666_CR12","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.ejheart.2003.12.015","volume":"6","author":"C Hall","year":"2004","unstructured":"Hall, C. Essential biochemistry and physiology of (NT-pro) BNP. Eur. J. Heart Failure 6(3), 257\u2013260 (2004).","journal-title":"Eur. J. Heart Failure"},{"key":"62666_CR13","doi-asserted-by":"crossref","unstructured":"Nakao, K., Ogawa, Y., Suga, Si., Imura, H. (1996). Molecular biology and biochemistry of the natriuretic peptide system. In: Lindpaintner, K., Ganten, D. (eds) Molecular Reviews in Cardiovascular Medicine. Springer, Dordrecht. https:\/\/doi.org\/10.1007\/978-94-009-0083-7_9","DOI":"10.1007\/978-94-009-0083-7_9"},{"issue":"2","key":"62666_CR14","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.chest.2019.02.004","volume":"156","author":"RL Benza","year":"2019","unstructured":"Benza, R. L. et al. Predicting survival in patients with pulmonary arterial hypertension: the REVEAL risk score calculator 2. 0 and comparison with ESC\/ERS-based risk assessment strategies. Chest 156(2), 323\u2013337 (2019).","journal-title":"Chest"},{"issue":"2","key":"62666_CR15","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1161\/CIRCULATIONAHA.109.898122","volume":"122","author":"RL Benza","year":"2010","unstructured":"Benza, R. L. et al. Predicting survival in pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management (REVEAL). Circulation 122(2), 164\u2013172 (2010).","journal-title":"Circulation"},{"issue":"23","key":"62666_CR16","doi-asserted-by":"publisher","first-page":"8325","DOI":"10.3390\/jcm14238325","volume":"14","author":"\u0141 Ledzi\u0144ski","year":"2025","unstructured":"Ledzi\u0144ski, \u0141 et al. Personalized medicine in pulmonary arterial hypertension: utilizing artificial intelligence for death prevention. J. Clin. Med. 14(23), 8325. https:\/\/doi.org\/10.3390\/jcm14238325 (2025).","journal-title":"J. Clin. Med."},{"issue":"8","key":"62666_CR17","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1164\/rccm.202311-2196OC","volume":"210","author":"JV Scott","year":"2024","unstructured":"Scott, J. V. et al. Novel liver injury phenotypes and outcomes in clinical trial participants with pulmonary hypertension. Am. J. Respir. Crit. Care Med. 210(8), 1045\u20131056 (2024).","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"62666_CR18","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/s12931-021-01917-3","volume":"22","author":"F Tian","year":"2021","unstructured":"Tian, F. et al. NT-pro BNP in AECOPD-PH: old biomarker, new insights-based on a large retrospective case-controlled study. Respir. Res. 22(1), 321 (2021).","journal-title":"Respir. Res."},{"issue":"7","key":"62666_CR19","first-page":"101312","volume":"10","author":"AC Park","year":"2025","unstructured":"Park, A. C. & Schilling, J. D. The Cardiohepatic Axis in Heart Failure. Basic Transl. Sci. 10(7), 101312 (2025).","journal-title":"Basic Transl. Sci."},{"issue":"1","key":"62666_CR20","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s11897-014-0238-0","volume":"12","author":"G Poelzl","year":"2015","unstructured":"Poelzl, G. & Auer, J. Cardiohepatic syndrome. Curr. Heart Fail. Rep. 12(1), 68\u201378 (2015).","journal-title":"Curr. Heart Fail. Rep."},{"issue":"6","key":"62666_CR21","doi-asserted-by":"publisher","first-page":"429","DOI":"10.14740\/cr1565","volume":"14","author":"MA Kalas","year":"2023","unstructured":"Kalas, M. A. et al. The association between non-clinically apparent liver fibrosis and pulmonary arterial hypertension in Hispanic patients. Cardiol. Res. 14(6), 429\u2013436 (2023).","journal-title":"Cardiol. Res."},{"key":"62666_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-045165","author":"C Luo","year":"2021","unstructured":"Luo, C. et al. Liver dysfunction in idiopathic pulmonary arterial hypertension: prevalence, characteristics and prognostic significance, a retrospective cohort study in China. BMJ Open https:\/\/doi.org\/10.1136\/bmjopen-2020-045165 (2021).","journal-title":"BMJ Open"},{"issue":"6","key":"62666_CR23","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/crj.13623","volume":"17","author":"C Hong","year":"2023","unstructured":"Hong, C. et al. Aetiological distribution of pulmonary hypertension and the value of transthoracic echocardiography screening in the respiratory department: A retrospective analysis from China. clin. Respir. J. 17(6), 536\u2013547 (2023).","journal-title":"clin. Respir. J."},{"issue":"5","key":"62666_CR24","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.echo.2013.01.006","volume":"26","author":"RC Steckelberg","year":"2013","unstructured":"Steckelberg, R. C. et al. Derivation of mean pulmonary artery pressure from noninvasive parameters. J. Am. Soc. Echocardiogr. 26(5), 464\u2013468 (2013).","journal-title":"J. Am. Soc. Echocardiogr."},{"issue":"1","key":"62666_CR25","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12872-022-02495-y","volume":"22","author":"T Abu","year":"2022","unstructured":"Abu, T. et al. Preoperative evaluation of pulmonary hypertension in lung transplant candidates: echocardiography versus right heart catheterization. BMC Cardiovasc. Disorders 22(1), 53 (2022).","journal-title":"BMC Cardiovasc. Disorders"},{"key":"62666_CR26","doi-asserted-by":"publisher","first-page":"132639","DOI":"10.1016\/j.ijcard.2024.132639","volume":"418","author":"MD Lyhne","year":"2025","unstructured":"Lyhne, M. D. et al. Right ventricular to pulmonary artery coupling in chronic thromboembolic pulmonary hypertension. Int. J. Cardiol. 418, 132639 (2025).","journal-title":"Int. J. Cardiol."},{"issue":"4","key":"62666_CR27","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.amjcard.2010.10.027","volume":"107","author":"S Ghio","year":"2011","unstructured":"Ghio, S. et al. Clinical and prognostic relevance of echocardiographic evaluation of right ventricular geometry in patients with idiopathic pulmonary arterial hypertension. Am. J. Cardiol. 107(4), 628\u2013632 (2011).","journal-title":"Am. J. Cardiol."},{"issue":"11","key":"62666_CR28","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1111\/echo.14125","volume":"35","author":"F Gual-Capllonch","year":"2018","unstructured":"Gual-Capllonch, F. et al. Pulmonary vascular resistance versus pulmonary artery pressure for predicting right ventricular remodeling and functional tricuspid regurgitation. Echocardiography 35(11), 1736\u20131745 (2018).","journal-title":"Echocardiography"},{"key":"62666_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2025.133347","volume":"434","author":"C Wan","year":"2025","unstructured":"Wan, C. et al. Prognostic effect of left ventricular-pulmonary arterial coupling indicator in pulmonary arterial hypertension. Int. J. Cardiol. 434, 133347 (2025).","journal-title":"Int. J. Cardiol."},{"issue":"5","key":"62666_CR30","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.jacc.2003.09.051","volume":"43","author":"HH Leuchte","year":"2004","unstructured":"Leuchte, H. H. et al. Clinical significance of brain natriuretic peptide in primary pulmonary hypertension. J. Am. Coll. Cardiol. 43(5), 764\u2013770 (2004).","journal-title":"J. Am. Coll. Cardiol."},{"key":"62666_CR31","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2023.13133","author":"Y Zhou","year":"2024","unstructured":"Zhou, Y. et al. Insights into the relationship between serum uric acid and pulmonary hypertension (review). Mol. Med. Rep. https:\/\/doi.org\/10.3892\/mmr.2023.13133 (2024).","journal-title":"Mol. Med. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-62666-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-62666-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-62666-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T23:45:59Z","timestamp":1792539959000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-62666-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["62666"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-62666-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"assertion":[{"value":"14 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Shanghai Jiaotong University School of Medicine, Renji Hospital Ethic Committee (Approval number: LY2025-122-B, NCT06979011). The requirement for written informed consent was waived by the ethics committee due to the retrospective nature of this study. All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The waiver of informed consent is based on the following reasons: 1) the research involves no more than minimal risk to the subjects; 2) the waiver will not adversely affect the rights and welfare of the subjects; and 3) it is practically impossible to obtain consent from all given the sample size and the retrospective design where contact information might be unavailable or outdated. Furthermore, all patient data were anonymized and de-identified prior to analysis to protect confidentiality.","order":2,"name":"Ethics","label":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"33137"}}